» Articles » PMID: 39311869

Exploring the Relationship Between Cycle Threshold Values and Oral Manifestations in COVID-19: a Comprehensive Overview

Overview
Specialty Dentistry
Date 2024 Sep 23
PMID 39311869
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This cross-sectional study aimed to compare oral manifestations between severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-positive and SARS-CoV-2-negative patients and to examine associations between oral symptoms, Ct values of E and N SARS-CoV-2 viral genes, and the implications of low Ct values indicating a high viral load, which is a predictive factor for the outcome of COVID-19.

Methods: A total of 353 participating patients were aged ≥18 years with clinical manifestations of COVID-19 infection and tested for SARS-CoV-2 carriage at the medical center, by reverse transcriptase polymerase chain reaction (RT-PCR). All patients filled out an anonymous digital questionnaire regarding oral and general symptoms and overall medical health.  Results: A significant association was found between SARS-CoV-2 carriage and dry mouth, unpleasant taste and changes in taste (p < 0.001); for example, 37.4% of the 147 SARS-CoV-2- positive participants had a dry mouth, compared to 18.9% of the 206 SARS-CoV-2- negative participants. Oral blisters were experienced by patients with an E gene Ct value of 10-20 (50%) or 21-30 (50%) (p = 0.041). Bad breath, dry mouth, unpleasant taste and changes in taste were mostly present in participants whose Ct values of both E and N genes were between 21 and 30.  Conclusions: This study found significant associations between low Ct values of E and N SARS-CoV-2 viral genes and high viral load, indicating that Ct values can serve as predictive factors for COVID-19 outcomes. The findings suggest that while oral symptoms are present, the Ct values and associated high viral loads are more critical indicators of disease severity and prognosis.

References
1.
Callaway E . The coronavirus is mutating - does it matter?. Nature. 2020; 585(7824):174-177. DOI: 10.1038/d41586-020-02544-6. View

2.
Ciotti M, Angeletti S, Minieri M, Giovannetti M, Benvenuto D, Pascarella S . COVID-19 Outbreak: An Overview. Chemotherapy. 2020; 64(5-6):215-223. PMC: 7179549. DOI: 10.1159/000507423. View

3.
Iranmanesh B, Khalili M, Amiri R, Zartab H, Aflatoonian M . Oral manifestations of COVID-19 disease: A review article. Dermatol Ther. 2020; 34(1):e14578. PMC: 7744903. DOI: 10.1111/dth.14578. View

4.
Chang M, Hur J, Park D . Interpreting the COVID-19 Test Results: A Guide for Physiatrists. Am J Phys Med Rehabil. 2020; 99(7):583-585. PMC: 7268832. DOI: 10.1097/PHM.0000000000001471. View

5.
Yuce M, Filiztekin E, Ozkaya K . COVID-19 diagnosis -A review of current methods. Biosens Bioelectron. 2020; 172:112752. PMC: 7584564. DOI: 10.1016/j.bios.2020.112752. View